Amorphous solid dispersion (ASD) is one of the most effective approaches for delivering
poorly soluble drugs. In ASDs, polymeric materials serve as the carriers in which the drugs …

Drug polymorphism, an established term used to describe the phenomenon that a drug can
exist in different crystalline phases, has attracted great interests in pharmaceutical field in …

The increasing use of renewable energy sources has highlighted the importance of energy
storages, and in particular of latent heat thermal energy storages (LHTESs). Among the …

Amorphous solid dispersions stabilized by one or more polymer (s) have been widely used
for delivering amorphous drugs with poor water solubilities, and they have gained great …

The molecules at the surface of a liquid have different organization and dynamics from those
in the bulk, potentially altering the rate of crystal nucleation and polymorphic selection, but …

Polymorphism, the ability of the same substance to crystallize in more than one crystal
structure, is a common phenomenon in organic crystals, influencing the physicochemical …

Polymorphism occurs widely in pharmaceutical solids, and must be thoroughly studied
during product development. Twenty-four years after ritonavir (RTV) Form II materialized, we …

Due to their measurable crystallization kinetics, oxide glass-formers are adequate systems
for evaluating theoretical approaches to describe and predict crystal nucleation dynamics …

Crystal nucleation rates have been measured in the supercooled melts of two richly
polymorphic glass-forming liquids: ROY and nifedipine (NIF). ROY or 5-methyl-2-[(2 …

Form Y04 of the compound ROY is a transient polymorph discovered by melt crystallization
in 2004, whose structure has not yet been determined. Here we report the structure of Form …